These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 8223852

  • 1. A new infectious mammary tumor virus in the milk of mice implanted with C4 hyperplastic alveolar nodules.
    Shakhov AN, Wang H, Acha-Orbea H, Pauley RJ, Wei WZ.
    Eur J Immunol; 1993 Nov; 23(11):2765-9. PubMed ID: 8223852
    [Abstract] [Full Text] [Related]

  • 2. A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice.
    Yoshimoto T, Nagase H, Nakano H, Matsuzawa A, Nariuchi H.
    Eur J Immunol; 1994 Jul; 24(7):1612-9. PubMed ID: 7913038
    [Abstract] [Full Text] [Related]

  • 3. Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice.
    Gill R, Wang H, Bluethmann H, Iglesias A, Wei WZ.
    Cancer Res; 1994 Mar 15; 54(6):1529-35. PubMed ID: 8137259
    [Abstract] [Full Text] [Related]

  • 4. New infectious mammary tumor virus superantigen with V beta-specificity identical to staphylococcal enterotoxin B (SEB).
    Luther S, Shakhov AN, Xenarios I, Haga S, Imai S, Acha-Orbea H.
    Eur J Immunol; 1994 Aug 15; 24(8):1757-64. PubMed ID: 8056034
    [Abstract] [Full Text] [Related]

  • 5. Sequence similarity between the long terminal repeat coding regions of mammary-tumorigenic BALB/cV and renal-tumorigenic C3H-K strains of mouse mammary tumor virus.
    Kang JJ, Schwegel T, Knepper JE.
    Virology; 1993 Sep 15; 196(1):303-8. PubMed ID: 8395120
    [Abstract] [Full Text] [Related]

  • 6. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
    Baribaud F, Wirth S, Maillard I, Valsesia S, Acha-Orbea H, Diggelmann H.
    J Virol; 2001 Aug 15; 75(16):7453-61. PubMed ID: 11462017
    [Abstract] [Full Text] [Related]

  • 7. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain.
    Ando Y, Wajjwalku W, Niimi N, Hiromatsu K, Morishima T, Yoshikai Y.
    J Immunol; 1995 Jun 15; 154(12):6219-26. PubMed ID: 7759859
    [Abstract] [Full Text] [Related]

  • 8. Adoptive transfer of V beta 2-deleting activity with host cells from mice implanted with C4 preneoplastic hyperplastic alveolar nodules.
    Wei WZ, Wang H, Ficsor-Jacobs R, Pauley R.
    Cancer Res; 1992 Oct 01; 52(19):5183-9. PubMed ID: 1327503
    [Abstract] [Full Text] [Related]

  • 9. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
    Hodes RJ, Novick MB, Palmer LD, Knepper JE.
    J Immunol; 1993 Feb 15; 150(4):1422-8. PubMed ID: 8094408
    [Abstract] [Full Text] [Related]

  • 10. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
    Maillard I, Erny K, Acha-Orbea H, Diggelmann H.
    Eur J Immunol; 1996 May 15; 26(5):1000-6. PubMed ID: 8647159
    [Abstract] [Full Text] [Related]

  • 11. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
    Braun MY, Jouvin-Marche E, Marche PN, MacDonald HR, Acha-Orbea H.
    Eur J Immunol; 1995 Mar 15; 25(3):857-62. PubMed ID: 7705418
    [Abstract] [Full Text] [Related]

  • 12. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
    Golovkina TV, Dudley JP, Ross SR.
    J Immunol; 1998 Sep 01; 161(5):2375-82. PubMed ID: 9725233
    [Abstract] [Full Text] [Related]

  • 13. Identification of an endogenous mammary tumor virus involved in the clonal deletion of V beta 2 T cells.
    Jouvin-Marche E, Marche PN, Six A, Liebe-Gris C, Voegtle D, Cazenave PA.
    Eur J Immunol; 1993 Nov 01; 23(11):2758-64. PubMed ID: 8223851
    [Abstract] [Full Text] [Related]

  • 14. Deletion of CD4+ T cells and thymocytes by apoptosis in mouse mammary tumor virus (C4)-infected V beta 2 transgenic mice.
    Wang H, Gill RF, Lichlyter D, Iglesias A, Bluethmann H, Wei WZ.
    Eur J Immunol; 1994 Dec 01; 24(12):2950-6. PubMed ID: 7805721
    [Abstract] [Full Text] [Related]

  • 15. Exogenous mouse mammary tumor virus (MMTV) infection induces endogenous MMTV sag expression.
    Xu L, Wrona TJ, Dudley JP.
    Virology; 1996 Jan 15; 215(2):113-23. PubMed ID: 8560758
    [Abstract] [Full Text] [Related]

  • 16. Expression of mammary tumor virus proteins in preneoplastic outgrowth lines and mammary tumors of BALB/cV mice.
    Slagle BL, Lanford RE, Medina D, Butel JS.
    Cancer Res; 1984 May 15; 44(5):2155-62. PubMed ID: 6324998
    [Abstract] [Full Text] [Related]

  • 17. Lobuloalveolar differentiation and tumorigenesis: two separate activities of mouse mammary tumor virus.
    Squartini F, Basolo F, Bistocchi M.
    Cancer Res; 1983 Dec 15; 43(12 Pt 1):5879-82. PubMed ID: 6315219
    [Abstract] [Full Text] [Related]

  • 18. Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat.
    Günzburg WH, Heinemann F, Wintersperger S, Miethke T, Wagner H, Erfle V, Salmons B.
    Nature; 1993 Jul 08; 364(6433):154-8. PubMed ID: 8391646
    [Abstract] [Full Text] [Related]

  • 19. [Endogenous MMTV in the normal mammary gland and in dimethylanthracene-induced mammary cancer in BALB/c mice].
    Komarova EA, Kriukova IN, Chernov MV, Kazarov AR.
    Mol Gen Mikrobiol Virusol; 1987 Aug 08; (8):10-3. PubMed ID: 2825005
    [Abstract] [Full Text] [Related]

  • 20. Elimination of V beta 2 bearing T-cells in BALB/c mice implanted with syngeneic preneoplastic and neoplastic mammary lesions.
    Wei WZ, Ficsor-Jacobs R, Tsai SJ, Pauley R.
    Cancer Res; 1991 Jun 15; 51(12):3331-3. PubMed ID: 2040009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.